171 related articles for article (PubMed ID: 37644688)
21. Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009.
Jung GW; Dover DC; Salopek TG
Br J Dermatol; 2014 Jan; 170(1):136-43. PubMed ID: 24443913
[TBL] [Abstract][Full Text] [Related]
22. Incidence of invasive cancers following cutaneous malignant melanoma.
Levi F; La Vecchia C; Randimbison L; Te VC; Erler G
Int J Cancer; 1997 Sep; 72(5):776-9. PubMed ID: 9311593
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous malignant melanoma in Ethiopian patients histopathologic study of 50 cases from Tikur Anbessa Hospital.
Legesse TB; Schneider J
Ethiop Med J; 2011 Oct; 49(4):313-22. PubMed ID: 23409396
[TBL] [Abstract][Full Text] [Related]
24. Temporal trends in the incidence of cutaneous malignant melanoma among Caucasians in the San Francisco-Oakland MSA.
Horn-Ross PL; Holly EA; Brown SR; Aston DA
Cancer Causes Control; 1991 Sep; 2(5):299-305. PubMed ID: 1932542
[TBL] [Abstract][Full Text] [Related]
25. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of cutaneous malignant melanoma in Reunion Island.
Chirpaz E; Warocquier J; Filisetti C; Beylot-Barry M; Bertolotti A; Sultan N
Ann Dermatol Venereol; 2022 Mar; 149(1):39-44. PubMed ID: 35131081
[TBL] [Abstract][Full Text] [Related]
28. Incidence of cutaneous malignant melanoma in Denmark, 1978-2007.
Fuglede NB; Brinck-Claussen UØ; Deltour I; Boesen EH; Dalton SO; Johansen C
Br J Dermatol; 2011 Aug; 165(2):349-53. PubMed ID: 21466535
[TBL] [Abstract][Full Text] [Related]
29. Predicting cutaneous malignant melanoma patients' survival using deep learning: a retrospective cohort study.
Cai S; Li W; Deng C; Tang Q; Zhou Z
J Cancer Res Clin Oncol; 2023 Dec; 149(19):17103-17113. PubMed ID: 37755576
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous malignant melanoma--clinical epidemiology and survival.
Nair MK; Varghese C; Mahadevan S; Cherian T; Joseph F
J Indian Med Assoc; 1998 Jan; 96(1):19-20, 28. PubMed ID: 9601186
[TBL] [Abstract][Full Text] [Related]
31. The incidence and pathogenesis of invasive cutaneous malignant melanoma in Northern Ireland.
Gordon LG; Lowry WS
Br J Cancer; 1986 Jan; 53(1):75-80. PubMed ID: 3947518
[TBL] [Abstract][Full Text] [Related]
32. A histological comparison of cutaneous malignant melanoma between the Oxford Region and Western Australia.
Heenan PJ; Holman CD
Histopathology; 1982 Nov; 6(6):703-16. PubMed ID: 7160830
[TBL] [Abstract][Full Text] [Related]
33. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
[TBL] [Abstract][Full Text] [Related]
34. A new computerized methodology to analyse tumour site in relation to phenotypic traits and epidemiological characteristics of cutaneous malignant melanoma.
Gillgren P; Brattström G; Djureen Mårtensson E; Frisell J; Palmgren J; Ringborg U; Hansson J
Br J Dermatol; 2002 Jun; 146(6):1023-30. PubMed ID: 12072071
[TBL] [Abstract][Full Text] [Related]
35. Patient presentation, skin biopsy utilization and cutaneous malignant melanoma incidence and mortality in northern Italy: Trends and correlations.
Bucchi L; Mancini S; Zamagni F; Crocetti E; Dal Maso L; Ferretti S; Baldacchini F; Giuliani O; Ravaioli A; Vattiato R; Brustolin A; Candela G; Carone S; Carrozzi G; Cavallo R; Dinaro YM; Ferrante M; Iacovacci S; Mazzoleni G; Musolino A; Rizzello RV; Serraino D; Biggeri A; Stanganelli I; Falcini F;
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):293-302. PubMed ID: 36181283
[TBL] [Abstract][Full Text] [Related]
36. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis.
Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H
Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874
[TBL] [Abstract][Full Text] [Related]
37. Changing presentation of cutaneous malignant melanoma.
Klit A; Lassen CB; Olsen CH; Lock-Andersen J
Dan Med J; 2015 Oct; 62(10):A5142. PubMed ID: 26441390
[TBL] [Abstract][Full Text] [Related]
38. Estimating the cure proportion of malignant melanoma, an alternative approach to assess long term survival: a population-based study.
Andersson TM; Eriksson H; Hansson J; Månsson-Brahme E; Dickman PW; Eloranta S; Lambe M; Lambert PC
Cancer Epidemiol; 2014 Feb; 38(1):93-9. PubMed ID: 24447700
[TBL] [Abstract][Full Text] [Related]
39. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
40. Cutaneous Melanoma in Alpine Population: Incidence Trends and Clinicopathological Profile.
Buja A; Rugge M; De Luca G; Bovo E; Zorzi M; De Toni C; Cozzolino C; Vecchiato A; Del Fiore P; Spina R; Cinquetti S; Baldo V; Rossi CR; Mocellin S
Curr Oncol; 2022 Mar; 29(3):2165-2173. PubMed ID: 35323375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
